Aura Biosciences (AURA) Net Income (2020 - 2026)
Aura Biosciences filings provide 7 years of Net Income readings, the most recent being -$33.7 million for Q1 2026.
- Quarterly Net Income fell 22.56% to -$33.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$112.4 million through Mar 2026, down 19.46% year-over-year, with the annual reading at -$106.2 million for FY2025, 23.05% down from the prior year.
- Net Income hit -$33.7 million in Q1 2026 for Aura Biosciences, down from -$25.6 million in the prior quarter.
- Across five years, Net Income topped out at -$12.8 million in Q1 2022 and bottomed at -$33.7 million in Q1 2026.
- Average Net Income over 5 years is -$21.3 million, with a median of -$20.3 million recorded in 2024.
- The largest annual shift saw Net Income plummeted 116.15% in 2022 before it fell 1.35% in 2025.
- Aura Biosciences' Net Income stood at -$17.6 million in 2022, then fell by 25.65% to -$22.1 million in 2023, then fell by 13.92% to -$25.2 million in 2024, then fell by 1.35% to -$25.6 million in 2025, then plummeted by 31.83% to -$33.7 million in 2026.
- Per Business Quant, the three most recent readings for AURA's Net Income are -$33.7 million (Q1 2026), -$25.6 million (Q4 2025), and -$26.1 million (Q3 2025).